Treatment With Velcade (Bortezomib) Plus Dexamethasone (VD) or VD Plus Cyclophosphamide or VD Plus Lenalidomide in Patients With Multiple Myeloma Stabilized After 4 Cycles of VD
Clinical trial NCT00908232 · COMPLETED
Trial details
- NCT number
- NCT00908232
- Sponsor
- Janssen-Cilag International NV
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-05-01
- Primary completion
- 2011-08-01
- Enrollment
- 163
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.